Alan B. Frey
Affiliations: | New York University, New York, NY, United States |
Area:
Cell BiologyGoogle:
"Alan Frey"Children
Sign in to add traineeSasa D. Radoja | grad student | 2001 | NYU |
Mythili Koneru | grad student | 2004 | NYU |
David A. Schaer | grad student | 2005 | NYU |
Ngozi R. Monu | grad student | 2006 | NYU |
Edwin J. Vazquez-Cintron | grad student | 2011 | NYU |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ravindranathan S, Passang T, Li JM, et al. (2022) Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nature Communications. 13: 6418 |
Burgess HM, Pourchet A, Hajdu CH, et al. (2018) Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus. Molecular Therapy Oncolytics. 8: 71-81 |
Frey AB. (2017) The inhibitory signaling receptor protocadherin-18 regulates tumor infiltrating CD8+ T cell function. Cancer Immunology Research |
Bronte V, Brandau S, Chen SH, et al. (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nature Communications. 7: 12150 |
Moogk D, Zhong S, Yu Z, et al. (2016) Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets. Journal of Immunology (Baltimore, Md. : 1950) |
Pourchet A, Fuhrmann SR, Pilones KA, et al. (2016) CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy. Ebiomedicine. 5: 59-67 |
Yu C, Burns JC, Robinson WH, et al. (2016) Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model. Journal of Diabetes Research. 2016: 9083103 |
Frey AB. (2015) Suppression of T cell responses in the tumor microenvironment. Vaccine |
Pourchet A, Fuhrmann SR, Pilones KA, et al. (2015) CD8+ T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy Ebiomedicine |
Zhong S, Malecek K, Moogk D, et al. (2014) Engineering the immune response to "self" for effective cancer immunotherapy Journal For Immunotherapy of Cancer. 2: P22 |